[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"benign-ovarian-cyst\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:benign-ovarian-cyst":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,50],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":32,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100646805","ovarian-reserve-after-laparoscopic-cystectomy-for-endometriotic-and-non-endometriotic-cysts-100646805",false,"NCT07686783","Ovarian Reserve After Laparoscopic Cystectomy for Endometriotic and Non-Endometriotic Cysts","Ovarian Reserve After Laparoscopic Cystectomy for Endometriotic and Non-Endometriotic Cysts: A Comparative Prospective Cohort Study","Inclusion Criteria:\n\n* Female patients aged 18-45 years\n* Ovarian cyst measuring 6-15 cm in diameter, confirmed by transvaginal ultrasound or MRI\n* Cyst is persistent for more than 3 months if asymptomatic, OR any symptomatic cyst regardless of duration of diagnosis\n* Serum anti-Müllerian hormone (AMH) level ≥ 2 ng\u002FmL, measured within 1 month preoperatively\n* Willingness to participate and provide written informed consent\n\nExclusion Criteria:\n\n* Clinical or ultrasonic suspicion of ovarian malignancy\n* Ovarian cyst associated with pregnancy\n* Previous history of ovarian surgery\n* History of pelvic irradiation or chemotherapy\n* Known endocrine disorders affecting ovarian function (e.g., PCOS, premature ovarian insufficiency, thyroid dysfunction, hyperprolactinemia)\n* Current use of hormonal contraceptives or hormonal therapy within 3 months prior to enrollment\n* Presence of severe systemic disease that contraindicates surgery or general anesthesia\n* Refusal to participate or inability to provide informed consent","FEMALE","18 Years","45 Years",{"count":20,"type":21},60,"ESTIMATED","INTERVENTIONAL",[24],"NA","We will conduct this study to estimate the effect of laparoscopic cystectomy on ovarian reserve in endometriotic cysts versus non-endometriotic cysts.",[27,28,29,30,31],"Ovarian Cysts","Endometriosis","Benign Ovarian Cyst","Ovarian Reserve","Cystectomy",[33,31,34,35,36],"Laparoscopy","Endometriotic Ovarian Cysts","Benign Ovarian Cysts","Ovarian Reserve Markers","RECRUITING","2026-07-02",{"date":40,"type":41},"2026-07-07","ACTUAL",{"date":43,"type":21},"2026-06-30",{"date":45,"type":21},"2027-09",{"name":47,"class":48},"Benha University","OTHER",1,{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":11,"sex":16,"minAge":58,"maxAge":18,"enrollmentInfo":59,"targetDuration":4,"studyType":22,"phases":61,"briefSummary":62,"conditions":63,"keywords":64,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":5},"100411865","comparison-of-hemostatic-agent-to-suture-in-terms-of-hemostatic-function-and-preservation-of-ovarian-function-100411865","NCT04643106","Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function","A Multi-center, Randomized, Investigator-initiated Trial to Evaluate the Efficacy of PRreservation of ovArian Function, Hemostasis, and sAfety of a Hemostatic Agent Versus Suturing During Laparoscopic Ovarian Cystectomy for Endometrioma","PRAHA-2","Inclusion Criteria:\n\n* Informed consent.\n* Age: 19-45 year-old women\n* American Society of Anesthesiologists Physical Status classification 1 or 2\n* Plan of laparoscopic ovarian cystectomy for unilateral or bilateral ovarian endometriosis diagnosed by ultrasonography\n* Regular menstruation every 21-45 days\n\nExclusion Criteria:\n\n* No 'ovarian' endometriosis\n* Suspicious disease of ovarian malignancy\n* Age: 18 and younger, 46 and older\n* Pregnancy or breastfeeding.\n* Lower than 0.05 ng\u002Fml of serum Anti-mullerian hormone level\n* Hormonal therapy within recent 3 months\n* Considered as inappropriate by the researcher's judgment.","19 Years",{"count":60,"type":21},90,[24],"This study aims to evaluate the efficacy of preservation of ovarian function, hemostasis, and safety of a hemostatic agent versus suturing during laparoscopic ovarian cystectomy for ovarian endometriosis.",[29],[65,66,67,68,69,70,71],"endometriosis","endometrioma","ovarian cystectomy","ovarian function","ovarian reserve","hemostatic agent","suture","2023-06-23",{"date":74,"type":41},"2023-06-26",{"date":76,"type":41},"2021-02-25",{"date":78,"type":21},"2026-12-31",{"name":80,"class":48},"Seoul National University Hospital"]